Dovitinib lactate
-
Catalog numberB1615-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_nameDovitinib lactate; TKI258; CHIR258; Dovitinib; TKI 258; CHIR 258; TKI-258; CHIR-258; 4-amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one 2-hydroxypropanoate hydrate; multitargeted receptor tyrosine kinase inhibitor
-
DescriptionDovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGF-1R and HER2 in cell-free assays.
-
CAS Number915769-50-5
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₄H₂₉FN₆O₅
-
Molecular Weight500.53
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO
-
HandlingProtect from air and light
-
Tag LineA multitargeted RTK inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD16038433
-
PubChem CID16738710
-
SMILESCC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3.O
-
InChi1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11,24-25H,7-10,23H2,1H3/b20-18-
-
InChi KeyNOGSKCDVWBOZAQ-DJOSVPKASA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameDovitinib lactate
-
Alternative nameDovitinib lactate
-